Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1
about
Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1
description
im April 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 February 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2012
@uk
name
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@en
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@nl
type
label
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@en
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@nl
prefLabel
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@en
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@nl
P2093
P50
P1476
Spironolactone prevents altera ...... ticoid-regulated kinase type 1
@en
P2093
Beatriz Martín-Fernández
Dalton Vassallo
Luciana Venturini Rossoni
María Miana
Sandra Ballesteros
P304
P356
10.1113/EXPPHYSIOL.2011.063230
P577
2012-02-10T00:00:00Z